Comparison of severity of immunized versus non-immunized COVID-19 patients admitted to ICU: A prospective observational study

por Mhawish, Huda, Mady, Ahmed, Alaklobi, Faisal, Aletreby, Waleed, Asad, Tasmiya, Alodat, Mohammed, Alharthy, Abdulrahman, Abdulrahman, Basheer, Almahwi, Saleh, Memish, Ziad A.
Publicado 2021

Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series

por Mady, Ahmed, Aletreby, Waleed, Abdulrahman, Basheer, Lhmdi, Mohammed, Noor, Alfateh M., Alqahtani, Saleh A., Soliman, Ibrahim, Alharthy, Abdulrahman, Karakitsos, Dimitrios, Memish, Ziad A.
Publicado 2020

“Ventilator-free days” composite outcome in patients with SARS-CoV-2 infection treated with tocilizumab: A retrospective competing risk analysis

por Mady, Ahmed F., Abdulrahman, Basheer, Mumtaz, Shahzad A., Al-Odat, Mohammed A., Kuhail, Ahmed, Altoraifi, Rehab, Alshae, Rayan, Alharthy, Abdulrahman M., Aletreby, Waleed Th.
Publicado 2022

Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis

por Mady, Ahmed F., Abdulrahman, Basheer, Mumtaz, Shahzad A., Al-Odat, Mohammed A., Kuhail, Ahmed, Altoraifi, Rehab, Alshae, Rayan, Alharthy, Abdulrahman M., Karakitsos, Dimitrios, Aletreby, Waleed Th.
Publicado 2023

Deferoxamine in the management of COVID-19 adult patients admitted to ICU: a prospective observational cohort study

por Almutary, Abdulaziz M., Althunayyan, Saqer, Bagalb, Amal S., Mady, Ahmed F., Alenazi, Latifa, Mumtaz, Shahzad A., Al-Hammad, Zahrah, Abdulrahman, Basheer, Al-Odat, Mohammed A., Mhawish, Huda, Aletreby, Waleed Th., Altartouri, Maymouna, Memish, Ziad A.
Publicado 2023